» Articles » PMID: 32720042

Lymphedema Prevention Surgery: Improved Operating Efficiency Over Time

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2020 Jul 29
PMID 32720042
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lymphedema prevention surgery (LPS), which identifies, preserves, and restores lymphatic flow via lymphaticovenous bypasses (LVB), has demonstrated potential to decrease lymphedema in breast cancer patients requiring axillary lymph node dissection. Implementing this new operating technique requires additional operating room (OR) time and coordination. This study sought to evaluate the improvement of LPS technique and OR duration over time.

Methods: A prospective database of patients who underwent LPS at our institution from 2016 to 2019 was queried. Type of breast and reconstruction surgery, number of LVB performed, and OR times were collected. LPS details were compared by surgical group and year performed.

Results: Ninety-four patients underwent LPS, and 88 had complete OR time data available for analysis. Average age was 51 years, body mass index of 28, with an average of 15 lymph nodes removed. Reconstructive treatment groups included prosthetic reconstruction 56% (49), oncoplastic reduction 10% (9), and no reconstruction 34% (30). The number of patients undergoing LPS increased significantly from 2016 to 2019, and average number of LVB per patient doubled. In patients without reconstruction, the average time for LPS improved significantly from 212 to 87 min from 2016 to 2019 (p = 0.015) and similarly in patients undergoing LPS with prosthetic reconstruction from 238 to 160 min (p = 0.022).

Conclusions: LVB is an emerging surgical lymphedema prevention technique. While requiring additional surgical time, our results show that with refinement of technique, over 4 years, we were able to perform double the number of LVB per patient in half the OR time.

Citing Articles

Preventing Breast Cancer-Related Lymphedema: A Comprehensive Analysis of a 9-Year Single-Center Experience of Prophylactic Lymphovenous Bypass.

Cho M, Senger J, Park K, Hansotia K, Chratian S, Kadle R Ann Surg Oncol. 2024; 32(3):2007-2015.

PMID: 39715967 DOI: 10.1245/s10434-024-16640-8.


Changes on noncontrast magnetic resonance imaging following lymphatic surgery for upper extremity secondary lymphedema.

Babapour S, Lee C, Kim E, Kinney J, Fanning J, Singhal D J Vasc Surg Venous Lymphat Disord. 2024; 13(1):101962.

PMID: 39117036 PMC: 11764075. DOI: 10.1016/j.jvsv.2024.101962.


Supermicrosurgery lymphaticovenous and lymphaticolymphatic anastomosis: Technical detail and short-term follow-up for immediate lymphatic reconstruction in breast cancer treatment-related lymphedema prevention.

Brahma B, Yamamoto T, Panigoro S, Haryono S, Yusuf P, Priambodo P J Vasc Surg Venous Lymphat Disord. 2024; 12(4):101863.

PMID: 38428499 PMC: 11523392. DOI: 10.1016/j.jvsv.2024.101863.


Prevention of Breast Cancer-Related Lymphedema: An Up-to-Date Systematic Review of Different Surgical Approaches.

Pagliara D, Grieco F, Rampazzo S, Pili N, Serra P, Cuomo R J Clin Med. 2024; 13(2).

PMID: 38256688 PMC: 10817002. DOI: 10.3390/jcm13020555.


Advances in the prevention and treatment of breast cancer-related lymphedema.

Donahue P, MacKenzie A, Filipovic A, Koelmeyer L Breast Cancer Res Treat. 2023; 200(1):1-14.

PMID: 37103598 PMC: 10224871. DOI: 10.1007/s10549-023-06947-7.